In this respect, osteopontin (OPN) has been suggested to increase in fulminant hepatitis and Saito et al. [57] evaluated the benefit of silencing the mentioned gene by injecting anti-OPN siRNA, resulting in amelioration of liver tissue injury. The gene discussed is SPP1; the disease is Fulminant hepatitis.